Tumor Necrosis Factor (TNF) α Increases Collagen Accumulation and Proliferation in Intestinal Myofibroblasts via TNF Receptor 2
Open accessThe DOI matches its Crossref record; 49 of the 49 references it cites were found in a registry or an index.
Abstract
Intestinal fibrosis is an incurable complication of Crohn's disease involving increased numbers of collagen-producing myofibroblasts. Tumor necrosis factor (TNF) alpha has defined proinflammatory roles in Crohn's disease but its role in fibrosis is unclear. We tested the hypothesis that TNFalpha increases collagen accumulation and proliferation in intestinal myofibroblasts and has additive effects in combination with insulin-like growth factor (IGF) I. The mechanisms, TNF receptor isoform, and downstream signaling pathways were examined. Intestinal myofibroblasts from wild-type (WT) mice or mice homozygous for disruption of genes encoding TNFR1 (TNFR1-/-), TNFR2 (TNFR2-/-), or both (TNFR1/2-/-), were treated with TNFalpha, IGF-I, or both. In WT cells, TNFalpha and IGF-I stimulated type I collagen accumulation and DNA synthesis in an additive manner. IGF-I, but not TNFalpha, stimulated type I collagen gene activation. TNFalpha, but not IGF-I, induced tissue inhibitor of metalloproteinase-1 (TIMP-1) expression and reduced matrix metalloproteinases-2 activity and collagen degradation. TNFalpha also activated ERK1/2. These responses to TNFalpha were absent in TNFR2-/- and TNFR1/2-/- myofibroblasts, whereas TNFR1-/- cells showed similar responses to WT. Inhibition of ERK1/2 diminished TNFalpha induced DNA synthesis in WT and TNFR1-/- cells. Differences in TNFalpha-induced STAT3/DNA binding activity and not NFkappaB and AP-1 transcriptional activation correlated with impaired collagen accumulation/TIMP-1 induction in TNFR2(-/-) cells. Constitutively active STAT3 rescued TIMP-1 expression in TNFR2-/- cells. We conclude that TNFalpha and IGF-I may additively contribute to fibrosis during intestinal inflammation. TNFR2 is a primary mediator of fibrogenic actions of TNFalpha acting through ERK1/2 to stimulate proliferation and through STAT3 to stimulate TIMP-1 and inhibit collagen degradation.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“In atrial and intestinal myofibroblasts TNFα induces proliferation and collagen synthesis (119, 120).”
From Unraveling SSc Pathophysiology; The Myofibroblast (2018) · cites this paper as [119]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Bataller, R., & Brenner, D. A. (2005) · Journal of Clinical Investigation · doi:10.1172/jci24282 · Cited by 4,958
Pfeffer, K., Matsuyama, T., Kündig, T. M., Wakeham, A., Kishihara, K., Shahinian, A., Wiegmann, K., Ohashi, P. S., Krönke, M., & Mak, T. W. (1993) · Cell · doi:10.1016/0092-8674(93)90134-c · Cited by 1,677
Signal transduction by tumor necrosis factor and its relatives
Baud, V., & Karin, M. (2001) · Trends in Cell Biology · doi:10.1016/s0962-8924(01)02064-5 · Cited by 1,655
Rothe, J., Lesslauer, W., Lötscher, H., Lang, Y., Koebel, P., Köntgen, F., Althage, A., Zinkernagel, R., Steinmetz, M., & Bluethmann, H. (1993) · Nature · doi:10.1038/364798a0 · Cited by 1,245
Myofibroblasts. I. Paracrine cells important in health and disease
Powell, D. W., Mifflin, R. C., Valentich, J. D., Crowe, S. E., Saada, J. I., & West, A. B. (1999) · American Journal of Physiology-Cell Physiology · doi:10.1152/ajpcell.1999.277.1.c1 · Cited by 924
Myofibroblasts. II. Intestinal subepithelial myofibroblasts
Powell, D. W., Mifflin, R. C., Valentich, J. D., Crowe, S. E., Saada, J. I., & West, A. B. (1999) · American Journal of Physiology-Cell Physiology · doi:10.1152/ajpcell.1999.277.2.c183 · Cited by 566
The Myofibroblast in Pulmonary Fibrosis*
Phan, S. H. (2002) · Chest · doi:10.1378/chest.122.6_suppl.286s · Cited by 521
The role of epithelial-to-mesenchymal transition in renal fibrosis
Zeisberg, M., & Kalluri, R. (2004) · Journal of Molecular Medicine · doi:10.1007/s00109-003-0517-9 · Cited by 507
Sanlioglu, S., Williams, C. M., Samavati, L., Butler, N. S., Wang, G., McCray, P. B., Ritchie, T. C., Hunninghake, G. W., Zandi, E., & Engelhardt, J. F. (2001) · Journal of Biological Chemistry · doi:10.1074/jbc.m102061200 · Cited by 395
von Lampe, B., Barthel, B., Coupland, S. E., Riecken, E.-O., & Rosewicz, S. (2000) · Gut · doi:10.1136/gut.47.1.63 · Cited by 386
Research works printed but not linked: 8
- Zimmermann, E., and Lund, P. K. (2004) in Kirsner's Inflammatory Bowel Diseases (Sartor, R. B., and Sandborn, W. J., eds) Sixth Ed., pp. 219 -229, Elsevier Inc., New York
- Guo, G., Morrissey, J., McCracken, R., Tolley, T., Liapis, H., and Klahr, S. (2001) Am. J. Physiol. 280, F777-F785
- Simmons, J. G., Pucilowska, J. B., and Lund, P. K. (1999) Am. J. Physiol. 276, G817-G827
- Williams, K. L., Fuller, C. R., Fagin, J., and Lund, P. K. (2002) Am. J. Physiol. 283, G875-G885
- Krempen, K., Grotkopp, D., Hall, K., Bache, A., Gillan, A., Rippe, R. A., Brenner, D. A., and Breindl, M. (1999) Gene Expr. 8, 151-163
- Simmons, J. G., Pucilowska, J. B., Keku, T. O., and Lund, P. K. (2002) Am. J. Physiol. 283, G809 -G818 33. van Tol, E. A., Holt, L., Li, F. L., Kong, F. M., Rippe, R., Yamauchi, M., Pucilowska, J., Lund, P. K., and Sartor, R. B. (1999) Am. J. Physiol. 277, G245-G255
- van Tol, 1999, Am. J. Physiol., 277, G245
- Miscia, S., Marchisio, M., Grilli, A., Di Valerio, V., Centurione, L., Sabatino, G., Ga- raci, F., Zauli, G., Bonvini, E., and Di Baldassarre, A. (2002) Cell Growth & Differ. 13, 13-18
Cited by
Items 101–200 of 233
Saw, V. P. J., Dart, R., GALATOWICZ, G. E., Daniels, J. T., Dart, J. K. G., & Calder, V. L. (2009) · Investigative Ophthalmology & Visual Science · doi:10.1167/iovs.08-3345 · Cited by 37
Kim, S.-E., Ko, I.-G., Jin, J.-J., Hwang, L., Kim, C.-J., Kim, S.-H., Han, J.-H., & Jeon, J. W. (2020) · BioMed Research International · doi:10.1155/2020/2169083 · Cited by 35
Attenuating Immune Response of Macrophage by Enhancing Hydrophilicity of Ti Surface
Dai, X., Wei, Y., Zhang, X., Meng, S., Mo, X., Liu, X., Deng, X., Zhang, L., & Deng, X. (2015) · Journal of Nanomaterials · doi:10.1155/2015/712810 · Cited by 35
Zakaria, E. M., El‐Maraghy, N. N., Ahmed, A. F., Ali, A. A., & El‐Bassossy, H. M. (2017) · Naunyn-Schmiedeberg s Archives of Pharmacology · doi:10.1007/s00210-017-1360-9 · Cited by 34
Matsuzaki, S., Pouly, J. L., & Canis, M. J. (2020) · Scientific Reports · doi:10.1038/s41598-020-66298-x · Cited by 36
Genah, S., Cialdai, F., Ciccone, V., Sereni, E., Morbidelli, L., & Monici, M. (2021) · Biomedicines · doi:10.3390/biomedicines9030307 · Cited by 38
Freitas, M. O., Fonseca, A. P. R., Aguiar, M. T., Dias, C. C., Avelar, R. L., Sousa, F. B., Alves, A. P. N. N., & Silva, P. G. D. B. (2022) · Inflammopharmacology · doi:10.1007/s10787-022-01046-3 · Cited by 33
Pozharskaya, T., Liang, J. Z., & Lane, A. P. (2013) · International Forum of Allergy & Rhinology · doi:10.1002/alr.21187 · Cited by 33
Inflammation accelerating intestinal fibrosis: from mechanism to clinic
Xin, S., Liu, X., He, C., Gao, H., Wang, B., Hua, R., Gao, L., Shang, H., Sun, F., & Xu, J. (2024) · European journal of medical research · doi:10.1186/s40001-024-01932-2 · Cited by 41
Molecular mechanism of Gd@C82(OH)22 increasing collagen expression: Implication for encaging tumor
Liu, J., Kang, S.-G., Wang, P., Wang, Y., Lv, X., Liu, Y., Wang, F., Gu, Z., Yang, Z., Weber, J. K., et al. (2017) · Biomaterials · doi:10.1016/j.biomaterials.2017.10.027 · Cited by 34
Filidou, E., Valatas, V., Drygiannakis, I., Arvanitidis, K. I., Vradelis, S., Kouklakis, G., Kolios, G. C., & Bamias, G. (2018) · Inflammatory Bowel Diseases · doi:10.1093/ibd/izy204 · Cited by 36
SMAC mimetics as potential cancer therapeutics in myeloid malignancies
Boddu, P. C., Carter, B. Z., Verstovšek, S., & Pemmaraju, N. (2019) · British Journal of Haematology · doi:10.1111/bjh.15829 · Cited by 36
Immunological roles of intestinal mesenchymal cells
Thomson, C. A., Nibbs, R. J. B., McCoy, K. D., & Mowat, A. M. (2020) · Immunology · doi:10.1111/imm.13191 · Cited by 34
Oxidative state and IL-6 production in intestinal myofibroblasts of Crohnʼs disease patients
Catarzi, S., Favilli, F., Romagnoli, C., Marcucci, T., Picariello, L., Tonelli, F., VINCENZINI, M. T., & Iantomasi, T. (2010) · Inflammatory Bowel Diseases · doi:10.1002/ibd.21552 · Cited by 36
The Role of STAT1 for Crosstalk between Fibroblasts and Colon Cancer Cells
Kaler, P., Owusu, B. Y., Augenlicht, L. H., & Klampfer, L. (2014) · Frontiers in Oncology · doi:10.3389/fonc.2014.00088 · Cited by 36
MMPs/TIMPs and inflammatory signalling de‐regulation in human incisional hernia tissues
Guillem‐Marti, J., Díaz, R., Quiles, M., Cano, M. L., Vilallonga, R., Huguet, P., y Cajal, S. R., Niubo, A. S., Reventós, J., Armengol, M., et al. (2008) · Journal of Cellular and Molecular Medicine · doi:10.1111/j.1582-4934.2008.00637.x · Cited by 36
Use of biologics and other novel therapies for the treatment of systemic sclerosis
Bruni, C., Praino, E., Allanore, Y., Distler, O., Gabrielli, A., Iannone, F., & Matucci‐Cerinic, M. (2016) · Expert Review of Clinical Immunology · doi:10.1080/1744666x.2017.1263153 · Cited by 32
In vitro evaluation of anti‐fibrotic effects of select cytokines for vocal fold scar treatment
Chen, H., Erndt‐Marino, J. D., Díaz‐Rodríguez, P., Kulwatno, J., Jimenez‐Vergara, A. C., Thibeault, S. L., & Hahn, M. S. (2018) · Journal of Biomedical Materials Research Part B Applied Biomaterials · doi:10.1002/jbm.b.34198 · Cited by 31
Ono, Y., Hirai, F., Matsui, T., Beppu, T., Yano, Y., Takatsu, N., Takaki, Y., Nagahama, T., Hisabe, T., Yao, K., et al. (2012) · Digestive Endoscopy · doi:10.1111/j.1443-1661.2012.01315.x · Cited by 29
Effect of TNFα blockade on UVB-induced inflammatory cell migration and collagen loss in mice
Sharma, M. R., Mitrani, R., & Werth, V. P. (2020) · Journal of Photochemistry and Photobiology B Biology · doi:10.1016/j.jphotobiol.2020.112072 · Cited by 41
Agista, A. Z., Rusbana, T. B., Islam, J., Ohsaki, Y., Sultana, H., Hirakawa, R., Watanabe, K., Nochi, T., Ardiansyah, A., Budijanto, S., et al. (2021) · Nutrients · doi:10.3390/nu13061869 · Cited by 30
Romagnoli, C., Marcucci, T., Picariello, L., Tonelli, F., VINCENZINI, M. T., & Iantomasi, T. (2012) · International Journal of Colorectal Disease · doi:10.1007/s00384-012-1632-2 · Cited by 29
Callaghan, N. I., Rempe, C. N., Froom, Z. S. C. S., Medd, K., & Huyer, L. D. (2024) · Materials Advances · doi:10.1039/d4ma00333k · Cited by 32
The possible role of trauma in skin tags through the release of mast cell mediators
Hay, R. M. A., Safoury, O. E., Fawzy, M., Hassan, A., Maadawi, Z. M. E., & Rashed, L. (2011) · Indian Journal of Dermatology · doi:10.4103/0019-5154.91819 · Cited by 27
Cortez‐Cooper, M. Y., Meaders, E., Stallings, J., Haddow, S., Kraj, B., Sloan, G. J., McCully, K. K., & Cannon, J. G. (2013) · Vascular Medicine · doi:10.1177/1358863x13508336 · Cited by 36
The Pathogenesis and Clinical Management of Stricturing Crohn Disease
Schmoyer, C. J., Saidman, J., Bohl, J. L., Bierly, C. L., Kuemmerle, J. F., & Bickston, S. J. (2021) · Inflammatory Bowel Diseases · doi:10.1093/ibd/izab038 · Cited by 26
Genes regulated by caloric restriction have unique roles within transcriptional networks
Swindell, W. R. (2008) · Mechanisms of Ageing and Development · doi:10.1016/j.mad.2008.06.001 · Cited by 27
Yin, H., Wang, B., Zhang, J., Lin, H., Qiao, Y., Wang, R., & Liu, F. (2008) · Journal of Ethnopharmacology · doi:10.1016/j.jep.2008.03.022 · Cited by 24
The Role of TGF-β in Allergic Inflammation
Schmidt‐Weber, C. B., & Blaser, K. (2006) · Immunology and Allergy Clinics of North America · doi:10.1016/j.iac.2006.02.011 · Cited by 26
Biological Mechanisms and Therapeutic Opportunities in Mammographic Density and Breast Cancer Risk
Archer, M., Dasari, P., Evdokiou, A., & Ingman, W. V. (2021) · Cancers · doi:10.3390/cancers13215391 · Cited by 24
Levy, C. S., Slomiansky, V., Gattelli, A., Nahmod, K. A., Pelisch, F., Blaustein, M., Srebrow, A., Coso, O. A., & Kordon, E. C. (2010) · Journal of Cellular Biochemistry · doi:10.1002/jcb.22595 · Cited by 23
Han, C., Wu, W., Alé, A., Kim, M. S., & Cai, D. (2016) · Journal of Biological Chemistry · doi:10.1074/jbc.m116.730408 · Cited by 26
The Molecular Role of Immune Cells in Dilated Cardiomyopathy
Wang, E., Zhou, R., Li, T., Hua, Y., Zhou, K., Li, Y., Luo, S., & An, Q. (2023) · Medicina · doi:10.3390/medicina59071246 · Cited by 28
Ma, R., Qiang, J., Shi, Y., Wenjun, D., & Chunsheng, W. (2019) · Journal of Cardiovascular Pharmacology · doi:10.1097/fjc.0000000000000742 · Cited by 23
Cytokine Regulation of Teleost Inflammatory Responses
Grayfer, L., & Belosevic, M. (2012) · InTech eBooks · doi:10.5772/53505 · Cited by 27
Regulation of intestinal epithelial homeostasis by mesenchymal cells
Kayama, H., & Takeda, K. (2024) · Inflammation and Regeneration · doi:10.1186/s41232-024-00355-0 · Cited by 26
Panagiotidis, G., Vásquez‐Pacheco, E., Chu, X., Seeger, W., Agha, E. E., Bellusci, S., & Lingampally, A. (2025) · Frontiers in Immunology · doi:10.3389/fimmu.2025.1609509 · Cited by 25
Cytokine and anti-cytokine therapies in prevention or treatment of fibrosis in IBD
Jacob, N., Targan, S. R., & Shih, D. Q. (2016) · United European Gastroenterology Journal · doi:10.1177/2050640616649356 · Cited by 53
Alizadeh, S., Mahboobi, L., Nasiri, M., Khosrowpour, Z., Khosravimelal, S., Asgari, F., Gholipour-Malekabadi, M., Razavi-Toosi, S. M. T., Chauhan, N. P. S., Ghobadi, F., et al. (2024) · ACS Applied Bio Materials · doi:10.1021/acsabm.3c00747 · Cited by 24
Zhu, A. S., Mustafa, T., Connell, J. P., & Grande-Allen, K. J. (2020) · Acta Biomaterialia · doi:10.1016/j.actbio.2021.03.075 · Cited by 22
Dar, A. I., Randhawa, S., Verma, M., & Acharya, A. (2023) · ACS Applied Materials & Interfaces · doi:10.1021/acsami.3c08166 · Cited by 19
Jeong, S. J., Ku, N. S., Han, S. H., Choi, J. Y., Kim, C. O., Song, Y. G., & Kim, J. M. (2015) · Clinica Chimica Acta · doi:10.1016/j.cca.2015.03.015 · Cited by 18
Luo, M., Yang, Y., Luo, D., Liu, L., Zhang, Y., Xiao, F., Yang, J., Zhang, C., Fu, S., & Luo, Z. (2016) · Oncotarget · doi:10.18632/oncotarget.13093 · Cited by 18
Colon Fibroblasts and Inflammation: Sparring Partners in Colorectal Cancer Initiation?
Onfroy-Roy, L., Hamel, D., Malaquin, L., & Ferrand, A. (2021) · Cancers · doi:10.3390/cancers13081749 · Cited by 20
Liu, J., Zhang, L., Wang, Z., Chen, S., Feng, S., He, Y., & Zhang, S. (2022) · Frontiers in Pharmacology · doi:10.3389/fphar.2022.844685 · Cited by 21
Effect of infliximab on the healing of intestinal anastomosis. An experimental study in rats
Papaconstantinou, I. G., Zeglinas, C., Gazouli, M., Nastos, C., Yiallourou, A., Lykoudis, P. M., Evangelou, K., Papalois, A. E., Papaioannou, M. D., Vlachogiannakos, J., et al. (2014) · International Journal of Surgery · doi:10.1016/j.ijsu.2014.07.271 · Cited by 16
Kawasaki, H., Saotome, T., Usui, T., Ohama, T., & Sato, K. (2017) · Oncology Reports · doi:10.3892/or.2017.5520 · Cited by 17
Ascidian (chordate-tunicate) and mammalian heparin enemas attenuate experimental diversion colitis
Alvarenga, V., Pacheco, R. G., Espósito, C. C., Buongusto, F., Castelo-Branco, M. T. L., Madi, K., Belmiro, C. L. R., Pavão, M. S. G., de Souza, H. S. P., & Schanaider, A. (2013) · Surgery · doi:10.1016/j.surg.2013.06.057 · Cited by 15
Eosinophilic esophagitis: novel concepts regarding pathogenesis and clinical manifestations
Sciumè, G. D., Visaggi, P., Sostilio, A., TARDUCCI, L., Pugno, C., Frazzoni, M., Ricchiuti, A., Bellini, M., Giannini, E. G., Marchi, S., et al. (2022) · Minerva Gastroenterology · doi:10.23736/s2724-5985.20.02807-x · Cited by 25
Molecular and Cellular Pathways as Treatment Targets for Biologic Therapies in Systemic Sclerosis
Dimitroulas, T., Daoussis, D., Garyfallos, A., Sfikakis, P. P., & Kitas, G. D. (2015) · Current Medicinal Chemistry · doi:10.2174/0929867322666150209161224 · Cited by 15
Establishment of mouse intestinal myofibroblast cell lines
Kawasaki, H., Ohama, T., Hori, M., & Sato, K. (2013) · World Journal of Gastroenterology · doi:10.3748/wjg.v19.i17.2629 · Cited by 15
Mukherjee, M., Latif, M. L., Pritchard, D., & Bosquillon, C. (2013) · Journal of Pharmacological and Toxicological Methods · doi:10.1016/j.vascn.2013.05.007 · Cited by 20
Myokardfibrose: ein kardiopathophysiologischer Januskopf
Maisch, B., & Rupp, H. (2006) · Herz · doi:10.1007/s00059-006-2823-9 · Cited by 13
Intestinal myofibroblasts produce nitric oxide in response to combinatorial cytokine stimulation
Wu, J., Chitapanarux, T., Chen, Y., Soon, R. K., & Yee, H. F. (2012) · Journal of Cellular Physiology · doi:10.1002/jcp.24164 · Cited by 12
Alvarenga, V., da Silva, P. T., Bonfá, N. D., Pêgo, B., Nanini, H. F., Bernardazzi, C., Madi, K., Baetas‐da‐Cruz, W., Castelo-Branco, M. T. L., de Souza, H. S. P., et al. (2019) · Surgery · doi:10.1016/j.surg.2019.07.023 · Cited by 12
Immune Regulation of Mammary Fibroblasts and the Impact of Mammographic Density
Archer, M., Dasari, P., Walsh, D., Britt, K. L., Evdokiou, A., & Ingman, W. V. (2022) · Journal of Clinical Medicine · doi:10.3390/jcm11030799 · Cited by 11
Co-expression of fibrotic genes in inflammatory bowel disease; A localized event?
Dovrolis, N., Filidou, E., Tarapatzi, G., Kokkotis, G., Spathakis, M., Kandilogiannakis, L., Drygiannakis, I., Valatas, V., Arvanitidis, K. I., Karakasiliοtis, I., et al. (2022) · Frontiers in Immunology · doi:10.3389/fimmu.2022.1058237 · Cited by 11
Al-Khatib, S., Abdo, N. M., AL-Eitan, L. N., Al-Mistarehi, A.-H. W., Zahran, D. J., & Kewan, T. Z. (2020) · Asian Pacific Journal of Cancer Prevention · doi:10.31557/apjcp.2020.21.9.2783 · Cited by 10
Deoxynivalenol induces ovarian damage and uterine changes in prepubertal and adult mice
de Lemos, G. A. A., Gerez, J. R., Costa, J. B., Venâncio, E. J., Souza, M. M., Favaron, P. O., Greghi, J. R., da Glória, E. M., Staurengo‐Ferrari, L., Verri, W. A., Jr., et al. (2024) · Toxicon · doi:10.1016/j.toxicon.2024.108123 · Cited by 10
Intestinal Fibrosis in Crohn’s Disease: Pathophysiology, Diagnosis, and New Therapeutic Targets
Fousekis, F. S., Mpakogiannis, K. C., Mastorogianni, I. N., Lianos, G. D., Christodoulou, D. K., & Katsanos, K. H. (2025) · Journal of Clinical Medicine · doi:10.3390/jcm14124060 · Cited by 16
Guo, J.-F., Zhao, Y., Du, Q., Ren, Y., Wang, Y., Wang, Z., & Jin, W. (2022) · BioMed Research International · doi:10.1155/2022/2775434 · Cited by 9
Zhang, Q., Gui, Y., Zhao, L., Zhang, A., Fu, L., Cao, Z., & Li, J. (2023) · Journal of the Science of Food and Agriculture · doi:10.1002/jsfa.12705 · Cited by 9
Jin, J., Ko, I., Hwang, L., Kim, S., Jee, Y., Jeon, H., Park, S. B., & Jeon, J. W. (2024) · International Journal of Molecular Sciences · doi:10.3390/ijms25105076 · Cited by 10
What are the mechanisms of fibrosis in IBD?
Lund, P. K., & Rigby, R. J. (2008) · Inflammatory Bowel Diseases · doi:10.1002/ibd.20681 · Cited by 9
Self-citationTan, H., Tan, S., Teo, S. H., Roebuck, M. M., Frostick, S. P., & Kamarul, T. (2020) · PeerJ · doi:10.7717/peerj.8740 · Cited by 8
Unveiling the molecular Hallmarks of Peyronie’s disease: a comprehensive narrative review
Şahin, A., Babayev, H., Cirigliano, L., Preto, M., Falcone, M., Altıntaş, E., & Gül, M. (2024) · International Journal of Impotence Research · doi:10.1038/s41443-024-00845-2 · Cited by 10
Molecular Phenotyping and Mechanisms of Myocardial Fibrosis in Advanced Chronic Kidney Disease
Narayanan, G., Halim, A., Hu, A., Avin, K. G., Lu, T., Zehnder, D., Hato, T., Chen, N. X., Moe, S. M., & Lim, K. J. (2023) · Kidney360 · doi:10.34067/kid.0000000000000276 · Cited by 11
Kolloli, A., Ramasamy, S., Kumar, R., Nisa, A., Kaplan, G., & Subbian, S. (2023) · Frontiers in Immunology · doi:10.3389/fimmu.2023.1270414 · Cited by 7
Liu, S., Rong, L., Deng, J., Zhao, X., Liu, X., Xu, X., & Qin, Z. (2011) · Cellular and Molecular Immunology · doi:10.1038/cmi.2010.79 · Cited by 7
Artone, S., Ciafarone, A., Augello, F. R., Lombardi, F., Cifone, M. G., Palumbo, P., Cinque, B., & Latella, G. (2024) · International Journal of Molecular Sciences · doi:10.3390/ijms25168862 · Cited by 7
Zhang, Y., Guo, P., Yang, J., Li, L., Cheng, Y., Zhu, H., Xue, B., Gu, X. S., Dong, L., Jiang, C., et al. (2026) · ACS Applied Materials & Interfaces · doi:10.1021/acsami.5c23033 · Cited by 6
Sakib, S., & Zou, S. (2024) · Langmuir · doi:10.1021/acs.langmuir.3c02741 · Cited by 14
Interleukin 1β and tumor necrosis factor α promote hFOB1.19 cell viability via activating AP1.
Ying, H., Li, Q., & Zhao, C. (2016) · PubMed · Cited by 6
Schmiedlin‐Ren, P., Reingold, L. J., Broxson, C. S., Rittershaus, A. C., Brudi, J. S., Adler, J., Owens, S. R., & Zimmermann, E. M. (2016) · American Journal of Physiology-Gastrointestinal and Liver Physiology · doi:10.1152/ajpgi.00216.2015 · Cited by 8
Significance Of Gut-Blood Barrier In Health And Disease
Huć, T., Pham, K., Skrzypecki, J., & Ufnal, M. (2016) · European Journal of Biological Research · doi:10.5281/zenodo.60336 · Cited by 7
Tong, T., Cheng, B., Tie, S., Zhan, G., Ouyang, D., & Cao, J. (2022) · Medicine · doi:10.1097/md.0000000000031969 · Cited by 5
The aryl hydrocarbon receptor: A promising target for intestinal fibrosis therapy
Pan, Y., Deng, Y., Yang, H., & Yu, M. (2025) · Pharmacological Research · doi:10.1016/j.phrs.2025.107909 · Cited by 11
Acute Phase Proteins as Biomarkers of Disease: From Bench to Clinical Practice
Francisco, J., Arias, P., Canda-Sánchez, A., & Nogueir, M. (2011) · InTech eBooks · doi:10.5772/18258 · Cited by 5
Medical Therapy of Fibrostenotic Crohn's Disease
Siegmund, B. (2015) · Visceral Medicine · doi:10.1159/000435868 · Cited by 5
Biomarker expression in lung of rabbit with pulmonary fibrosis induced by ammonium perchlorate
Wu, F.-H., Guo, H.-X., Lin, M.-F., Chen, Z.-Z., Zhou, X., & Peng, K.-L. (2010) · Toxicology and Industrial Health · doi:10.1177/0748233710386406 · Cited by 5
The impact of ageing on the structural compositions of the mucosa of human colon
Baidoo, N., Rasis, E. D., Tahiri, D., & Sanger, G. J. (2025) · Tissue and Cell · doi:10.1016/j.tice.2025.103090 · Cited by 6
Application of glutaraldehyde to in-cell Western assay for normalization
Li, J., Wang, Z., He, G., Zhang, W., Qian, A., & Shang, P. (2009) · Analytical Biochemistry · doi:10.1016/j.ab.2009.12.013 · Cited by 5
Antmen, E., Muller, C. B., Calligaro, C., Dupret‐Bories, A., Barthès, J., Lavall�e, P., & Vrana, N. E. (2022) · Biomaterials Advances · doi:10.1016/j.bioadv.2022.212872 · Cited by 6
Pathogenesis of Crohn's Disease- and Ulcerative Colitis-Related Strictures
Ko, J. Z.-H., Abraham, J. P., & Shih, D. Q. (2018) · Elsevier eBooks · doi:10.1016/b978-0-12-811388-2.00003-8 · Cited by 4
Alizadeh, S., Mahboobi, L., Nasiri, M., Khosrowpour, Z., Khosravimelal, S., Asgari, F., Gholipour-Malekabadi, M., Razavi-Toosi, S. M. T., Chauhan, N. P. S., Ghobadi, F., et al. (2022) · Research Square · doi:10.21203/rs.3.rs-2187166/v1 · Cited by 4
Azithromycin Prevents Subglottic Stenosis in Mice
Ghaderi, D. D., Aronson, M. R., Mehta, A., Friedman, R. M., McDaid, K. S., Giordano, T., Jacobs, I. N., & Gottardi, R. (2024) · The Laryngoscope · doi:10.1002/lary.31754 · Cited by 3
Role of Inflammatory Cytokines in the Initiation and Progression of Pancreatic Cancer
Santharam, M. A., & Dhandapani, V. (2019) · Springer eBooks · doi:10.1007/978-981-32-9393-9_8 · Cited by 3
Arafat, E. A.-G., Ghoneim, F. M., & Elsamanoudy, A. Z. (2015) · The Egyptian Journal of Histology · doi:10.1097/01.ehx.0000459829.97943.23 · Cited by 3
Brodt, P. (2010) · Cancer metastasis · doi:10.1007/978-90-481-8833-8_10 · Cited by 4
Fibrosis in Ulcerative Colitis
Magro, F., & António, T. (2018) · Springer eBooks · doi:10.1007/978-3-319-90578-5_10 · Cited by 3
Single-cell Transcriptomic Analysis of Salivary Gland Endothelial CellsPreprint
Altrieth, A. L., Suarez, E., Nelson, D. A., Gabunia, S., & Larsen, M. (2023) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2023.06.22.545817 · Cited by 3
Chang, C., Tu, H., Peng, S.-Y., Hsu, H., & Jiang, S. (2025) · Journal of Inflammation · doi:10.1186/s12950-025-00454-w · Cited by 3
Nakata, R., Hosomi, S., Kobayashi, Y., Nishida, Y., Maruyama, H., Ominami, M., Nadatani, Y., Fukunaga, S., Otani, K., Kamata, N., et al. (2025) · BMC Gastroenterology · doi:10.1186/s12876-025-04386-w · Cited by 2
Cancer-Associated Fibroblasts: Heterogeneity and Bimodality in Oncogenesis
Lunina, N. A., Safina, D. R., & Kostrov, S. V. (2023) · Molecular Biology · doi:10.31857/s0026898423050105 · Cited by 2
Liu, Q., Huai Yu, W. A. N. G., & He, X. (2019) · Journal of Veterinary Medical Science · doi:10.1292/jvms.19-0157 · Cited by 2
Late-breaking news from the “4th International Meeting on Inflammatory Bowel Diseases” Capri, 2006
Latella, G., Fiocchi, C., & Caprilli, R. (2007) · Inflammatory Bowel Diseases · doi:10.1002/ibd.20127 · Cited by 2
Fischer, R. (2011) · OPUS Publication Server of the University of Stuttgart (University of Stuttgart) · doi:10.18419/opus-1905 · Cited by 2
Cancer-Associated Fibroblasts: Heterogeneity and Bimodality in Oncogenesis
Lunina, N. A., Safina, D. R., & Kostrov, S. V. (2023) · Molecular Biology · doi:10.1134/s0026893323050096 · Cited by 1
Wang, Y., Liu, L., & Wang, W. (2024) · Endocrine Metabolic & Immune Disorders - Drug Targets · doi:10.2174/0118715303332155240912050838 · Cited by 1
Evaluation of the Therapeutic Effect of PRP in the Urethral Stricture
Özbilgin, K., Temeltaş, G., & Pekmezci, Y. (2025) · Indian journal of clinical medicine · doi:10.1177/26339447251335094 · Cited by 1
Metadata
- Authors
- Theiss, A. L., Simmons, J. G., Jobin, C., & Lund, P. K.
- Affiliations
- University of North Carolina at Chapel Hill (US)
- Corresponding author
- Lund, P. Kay
- Venue
- Journal of Biological Chemistry
- Publisher
- Elsevier BV
- Published
- 2005-10
- Volume
- 280
- Issue
- 43
- Pages
- 36099-36109
- ISSN
- 0021-9258 (ISSN-L)
- OpenAlex
- W2116521851
- Cited by
- 233
- References
- 47
- Citations by year
- 2026: 11 · 2025: 8 · 2024: 12 · 2023: 10 · 2022: 16 · 2021: 14 · 2020: 11 · 2019: 10 · 2018: 11 · 2017: 6 · 2016: 13 · 2015: 9 · 2014: 13 · 2013: 14 · 2012: 13
- FWCI
- 4.81
- Type
- journal article
- Language
- en
- Open access
- hybrid
- doi.org
- Licence
- cc-by
- www.elsevier.com/tdm/userlicense/1.0/ (tdm)
- creativecommons.org/licenses/by/4.0/ (vor, 5477 d)
- Locations
- Journal of Biological Chemistry (publishedVersion, cc-by)
- PubMed (publishedVersion)
- Carolina Digital Repository (University of North Carolina at Chapel Hill) (submittedVersion)
- UNC Libraries
- Funders
- National Institutes of Health (DK-34987)
- National Cancer Institute (CA-160-86, P30CA016086)
- National Institute of Diabetes and Digestive and Kidney Diseases (R01DK040247, R01DK047769, P30DK034987)
- Center for Gastrointestinal Biology and Disease, School of Medicine, University of North Carolina at Chapel Hill
- Topics
- Health Sciences › Medicine › Gastroenterology › Inflammatory Bowel Disease
- Health Sciences › Medicine › Hepatology › Liver physiology and pathology
- Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Cardiac Fibrosis and Remodeling
- Keywords
- TNF-α, TNF receptor 2, intestinal myofibroblasts, intestinal fibrosis, Crohn's disease, collagen deposition, type I collagen, insulin-like growth factor I, myofibroblast proliferation, TIMP-1, MMP-2, ERK signaling, STAT3, TNF receptor 1, intestinal inflammation
- MeSH terms
- Animals, Collagen, DNA, Dose-Response Relationship, Drug, Enzyme Activation, Fibroblasts, Fibrosis, Genotype, Homozygote, Inflammation, Insulin-Like Growth Factor I, Intestinal Mucosa, Mice, Transgenic, RNA, RNA, Messenger, Time Factors, Transcription, Genetic, Tumor Necrosis Factor-alpha, Blotting, Northern, Blotting, Western, Signal Transduction, Transcriptional Activation, Up-Regulation, NF-kappa B, Receptors, Tumor Necrosis Factor, Transcription Factor AP-1, Tissue Inhibitor of Metalloproteinase-1, Mitogen-Activated Protein Kinase 1, Protein Isoforms, Matrix Metalloproteinase 2, Receptors, Tumor Necrosis Factor, Type II, Mitogen-Activated Protein Kinase 3, Cell Proliferation, Green Fluorescent Proteins, STAT3 Transcription Factor, Mice
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.